Supplementary Data1 from Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial
Year: 2026
Type: supplementary-materials
Abstract: Supplementary Tables 1-3.
Authors: Komal Jhaveri, Lisa D. Eli, Sara A. Hurvitz, Adam Brufsky, Ron Bose, María de Miguel, Nisha Unni, Sonya Reid, David I. Quinn, Devalingam Mahalingam, Cristina Saura Manich, José Ángel García-Sáenz, Alejandro Martínez-Bueno, Angel Guerrero-Zotano, Olivier Trédan, Hans Wildiers, Georg F. Bischof, Judith Bebchuk, David B. Solit
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7204944540